commerce
shāng yè
商业
Eli Lilly (pharmaceutical company)
Lǐlái
礼来
weight loss / weight reduction
jiǎnzhòng
减重
drugs / medications
yàowù
药物
sales revenue / sales figure
xiāoshòu é
销售额
to set (a record)
chuàng
创
all-time high / record high
lìshǐ xīngāo
历史新高
quarterly
jìdù
季度
revenue
yíngshōu
营收
year-over-year
tóngbǐ
同比
to surge / to skyrocket
biāoshēng
飙升
56 percent
56%
56%
Eli Lilly (pharmaceutical company)
Lǐlái
礼来
under the umbrella of / belonging to
qíxià
旗下
diabetes
tángniàobìng
糖尿病
drug / medication
yàowù
药物
Mounjaro (diabetes and weight loss drug by Eli Lilly)
Mounjaro
Mounjaro
quarterly
jìdù
季度
sales revenue
xiāoshòu é
销售额
to grow / to increase
zēngzhǎng
增长
125 percent
125%
125%
to / reaching
zhì
至
$8.7 billion
87 yì měiyuán
87亿美元
weight loss drug
jiǎnféi yào
减肥药
Zepbound (obesity treatment drug by Eli Lilly)
Zepbound
Zepbound
to grow
zēngzhǎng
增长
79 percent
79%
79%
to / reaching
zhì
至
$4.1 billion
41 yì měiyuán
41亿美元
May 1, 2026 at 7:00 AM
United States
Měiguó
美国
pharmaceutical
zhìyào
制药
giant / major player
jùtóu
巨头
Eli Lilly (pharmaceutical company)
Lǐlái
礼来
on (a date)
yú
于
April 30
4 yuè 30 rì
4月30日
to announce / to release
gōngbù
公布
first quarter
dìyī jìdù
第一季度
financial report / earnings report
cáibào
财报
revenue
yíngshōu
营收
year-over-year
tóngbǐ
同比
to grow / to increase
zēngzhǎng
增长
56 percent
56%
56%
to / reaching
zhì
至
$19.8 billion
198 yì měiyuán
198亿美元
diabetes
tángniàobìng
糖尿病
treatment / therapeutic
zhìliáo
治疗
drug / medication
yàowù
药物
Mounjaro (diabetes and weight loss drug)
Mounjaro
Mounjaro
sales revenue
xiāoshòu é
销售额
year-over-year
tóngbǐ
同比
to surge / to jump sharply
dàzhǎng
大涨
125 percent
125%
125%
to reach / to achieve
dádào
达到
$8.7 billion
87 yì měiyuán
87亿美元
weight loss medication
jiǎnféi yàowù
减肥药物
Zepbound (obesity treatment drug)
Zepbound
Zepbound
in / at
zài
在
the United States
Měiguó
美国
(structural particle)
de
的
sales revenue
xiāoshòu é
销售额
year-over-year
tóngbǐ
同比
to grow
zēngzhǎng
增长
79 percent
79%
79%
to / reaching
zhì
至
$4.1 billion
41 yì měiyuán
41亿美元
market
shìchǎng
市场
demand
xūqiú
需求
to continue / ongoing
chíxù
持续
strong / robust
qiángjìng
强劲
driven by / buoyed by
shòu
受
results / performance
yèjì
业绩
to drive / to boost
dàidòng
带动
Eli Lilly
Lǐlái
礼来
stock price / share price
gǔjià
股价
on the same day
dāngrì
当日
to rise / to go up
shàngzhǎng
上涨
nearly / close to
jìn
近
7 percent
7%
7%
market
shìchǎng
市场
sentiment / mood
qíngxù
情绪
noticeably / clearly
míngxiǎn
明显
to improve / to turn positive
hǎozhuǎn
好转
Eli Lilly
Lǐlái
礼来
thereupon / immediately
suíjí
随即
will / to
jiāng
将
year 2026
2026 nián
2026年
full-year
quánnián
全年
revenue
yíngshōu
营收
guidance / forecast
yùqī
预期
to raise / to revise upward
shàngtiáo
上调
to / in the range of
zhì
至
$82 billion
820 yì
820亿
to
zhì
至
$85 billion
850 yì měiyuán
850亿美元
in addition / furthermore
cǐwài
此外
the United States
Měiguó
美国
the FDA / Food and Drug Administration
Shípǐn hé Yàowù Guǎnlǐjú
食品和药物管理局
to approve
pīzhǔn
批准
(completion marker)
le
了
Eli Lilly
Lǐlái
礼来
under the umbrella of
qíxià
旗下
the first / the inaugural
shǒu kuǎn
首款
oral / taken by mouth
kǒufú
口服
weight loss drug
jiǎnféi yào
减肥药
Foundayo (oral weight loss pill by Eli Lilly)
Foundayo
Foundayo
further / additionally
jìnyībù
进一步
to expand
kuòzhǎn
扩展
(completion marker)
le
了
the company
gōngsī
公司
weight loss / weight management
jiǎnzhòng
减重
product line
chǎnpǐn xiàn
产品线